| Name |
Mocetinostat, Free Base
|
| Supplier |
Biorbyt
|
| Catalog |
orb61058
|
| Prices |
$289.00, $340.00, $349.00, $502.00, $748.00, $1,224.00, $1,913.00, $3,502.00
|
| Sizes |
10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g, 2 g
|
| Cas Number |
[726169-73-9]
|
| Pubchem |
9865515
|
| Chemical Name |
N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide
|
| Formula |
C23H20N6O
|
| Molecular Weight |
396.44 g/mol
|
| Purity |
>99% pure
|
| Description |
MGCD0103 (Mocetinostat) is a potent HDAC inhibitor for HDAC1, HDAC2 and HDAC3 with IC50 of 0.15 μM, 0.29 μM and 1.66 μM, respectively. Phase II clinical trial has been completed in patients with refractory chronic lymphocytic leukemia.
|
| Supplier Page |
Shop
|
